Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1360-0443 (Electronic) Linking ISSN: 09652140 NLM ISO Abbreviation: Addiction Subsets: MEDLINE

Publication: Oxford : Wiley-Blackwell
Original Publication: Abingdon, Oxfordshire, UK : Carfax Pub. Co., c1993-

Alcoholism/*diagnosis ; Marijuana Abuse/*diagnosis; Alcoholism/classification ; Alcoholism/epidemiology ; Argentina/epidemiology ; Australia/epidemiology ; Brazil/epidemiology ; Colombia/epidemiology ; Cross-Sectional Studies ; Diagnostic and Statistical Manual of Mental Disorders ; Humans ; International Classification of Diseases ; Iraq/epidemiology ; Marijuana Abuse/classification ; Marijuana Abuse/epidemiology ; Northern Ireland/epidemiology ; Poland/epidemiology ; Portugal/epidemiology ; Romania/epidemiology ; Spain/epidemiology ; Substance-Related Disorders/classification ; Substance-Related Disorders/diagnosis ; Substance-Related Disorders/epidemiology ; Surveys and Questionnaires ; World Health Organization

Background and Aims: The World Health Organization's (WHO's) proposed International Classification of Diseases, 11th edition (ICD-11) includes several major revisions to substance use disorder (SUD) diagnoses. It is essential to ensure the consistency of within-subject diagnostic findings throughout countries, languages and cultures. To date, agreement analyses between different SUD diagnostic systems have largely been based in high-income countries and clinical samples rather than general population samples. We aimed to evaluate the prevalence of, and concordance between diagnoses using the ICD-11, The WHO's ICD 10th edition (ICD-10) and the Diagnostic and Statistical Manual of Mental Disorders, 4th and 5th editions (DSM-IV, DSM-5); the prevalence of disaggregated ICD-10 and ICD-11 symptoms; and variation in clinical features across diagnostic groups.
Design: Cross-sectional household surveys.
Setting: Representative surveys of the general population in 10 countries (Argentina, Australia, Brazil, Colombia, Iraq, Northern Ireland, Poland, Portugal, Romania and Spain) of the World Mental Health Survey Initiative.
Participants: Questions about SUDs were asked of 12 182 regular alcohol users and 1788 cannabis users.
Measurements: Each survey used the World Mental Health Survey Initiative version of the WHO Composite International Diagnostic Interview version 3.0 (WMH-CIDI).
Findings: Among regular alcohol users, prevalence (95% confidence interval) of life-time ICD-11 alcohol harmful use and dependence were 21.6% (20.5-22.6%) and 7.0% (6.4-7.7%), respectively. Among cannabis users, 9.3% (7.4-11.1%) met criteria for ICD-11 harmful use and 3.2% (2.3-4.0%) for dependence. For both substances, all comparisons of ICD-11 with ICD-10 and DSM-IV showed excellent concordance (all κ ≥ 0.9). Concordance between ICD-11 and DSM-5 ranged from good (for SUD and comparisons of dependence and severe SUD) to poor (for comparisons of harmful use and mild SUD). Very low endorsement rates were observed for new ICD-11 feature for harmful use ('harm to others'). Minimal variation in clinical features was observed across diagnostic systems.
Conclusions: The World Health Organization's proposed International Classification of Diseases, 11th edition (ICD-11) classifications for substance use disorder diagnoses are highly consistent with the ICD 10th edition and the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Concordance between ICD-11 and the DSM 5th edition (DSM-5) varies, due largely to low levels of agreement for the ICD harmful use and DSM-5 mild use disorder. Diagnostic validity of self-reported 'harm to others' is questionable.
(© 2018 Society for the Study of Addiction.)

Comment in: Addiction. 2019 Mar;114(3):553-554. (PMID: 30729599)

Subst Abuse. 2016 Jan 20;9(Suppl 2):99-106. (PMID: 26819555)
Addiction. 1995 May;90(5):637-45. (PMID: 7795500)
Lancet Psychiatry. 2015 Apr;2(4):314-22. (PMID: 26360084)
Alcohol Clin Exp Res. 2002 Jul;26(7):980-7. (PMID: 12170107)
Alcohol Clin Exp Res. 2006 Jul;30(7):1165-75. (PMID: 16792564)
Lancet Psychiatry. 2016 Jul;3(7):673-84. (PMID: 27371989)
Am J Psychiatry. 2003 Jan;160(1):4-12. (PMID: 12505793)
Drug Alcohol Depend. 2006 Jan 4;81(1):21-6. (PMID: 16005578)
Am J Psychiatry. 1970 Jan;126(7):983-7. (PMID: 5409569)
Addiction. 2006 Oct;101(10):1451-62. (PMID: 16968347)
Br Med J. 1976 May 1;1(6017):1058-61. (PMID: 773501)
Br J Pharmacol. 2010 Jun;160(3):511-22. (PMID: 20590561)
Psychol Med. 1989 Feb;19(1):45-55. (PMID: 2657832)
Drug Alcohol Depend. 1997 Sep 25;47(3):217-26. (PMID: 9306047)
World Psychiatry. 2015 Feb;14(1):82-90. (PMID: 25655162)
Arch Gen Psychiatry. 1980 Jun;37(6):699-706. (PMID: 7387341)
Drug Alcohol Depend. 1998 Mar 1;50(1):19-26. (PMID: 9589269)
BMC Genomics. 2008 Oct 16;9:488. (PMID: 18925949)
Drug Alcohol Depend. 1998 Aug 1;51(3):253-63; discussion 267-8. (PMID: 9787998)
Lancet. 2012 Jan 7;379(9810):55-70. (PMID: 22225671)
Int J Methods Psychiatr Res. 2006;15(4):167-80. (PMID: 17266013)
Arch Gen Psychiatry. 2004 Dec;61(12):1188-94. (PMID: 15583110)
Int J Methods Psychiatr Res. 2004;13(2):93-121. (PMID: 15297906)
J Stud Alcohol Drugs. 2015 Sep;76(5):773-80. (PMID: 26402358)
J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):165-173. (PMID: 18176333)
J Abnorm Psychol. 2006 Nov;115(4):807-14. (PMID: 17100538)
Alcohol Clin Exp Res. 2015 Apr;39(4):697-701. (PMID: 25778707)
Alcohol Clin Exp Res. 2016 Aug;40(8):1728-36. (PMID: 27426631)
J Abnorm Psychol. 2004 Feb;113(1):72-80. (PMID: 14992659)
Alcohol Clin Exp Res. 2017 Sep;41(9):1584-1592. (PMID: 28667763)
Drug Alcohol Depend. 2000 Jan 1;57(3):203-9. (PMID: 10661671)
J Stud Alcohol Drugs. 2012 Jul;73(4):699-701. (PMID: 22630808)

R01 DA016558 United States DA NIDA NIH HHS; 1081984 International National Health and Medical Research Council; R03 TW006481 United States TW FIC NIH HHS; R01 MH069864 United States MH NIMH NIH HHS; U01 MH060220 United States MH NIMH NIH HHS; R01 MH070884 United States MH NIMH NIH HHS; R01 DA044170 United States DA NIDA NIH HHS; 001 International WHO_ World Health Organization; R13 MH066849 United States MH NIMH NIH HHS

Keywords: Alcohol; DSM; ICD; World Mental Health Surveys; cannabis; diagnosis; substance use disorder

Date Created: 20181030 Date Completed: 20200402 Latest Revision: 20210109

20240105

PMC7059958

10.1111/add.14482

30370636